Skip to content

Released Feb 28, 2019, after the close

10-K filed Feb 28, 2019, 59 days after period end · 0001144204-19-011361

Q4 2018 · 10-K
Revenue$3.74M+12.7% vs Q4 2017−12.9% vs Q3 2018
Net Income-$26.16MN/M vs Q4 2017N/M vs Q3 2018
EPS Diluted-$1.03N/M vs Q4 2017N/M vs Q3 2018
Operating Incomederived-$26,322,000N/M
Operating Cash Flowderived-$16,727,000N/M
Free Cash Flowderived-$16,938,000N/M
Margins · derived
Operating margin-704.7%−334.3 pt vs Q4 2017
Net margin-700.4%−609.7 pt vs Q4 2017

What the release said

The release

Same quarter

MetricQ4 2018Q4 2017Q4 2016Q4 2015
Revenue$3.74M$3.32M——
Net Income-$26.16M-$3.01M-$11.55M-$7.75M
EPS Diluted-$1.03-$160.00-$0.67-$0.45

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR